chronic CV pt 1 Flashcards
exam findings for hyperlipidemia
skin lesions - eruptive or tendinous xanthomas
lipema retinalis
lipemic blood sample
dyslipidemia screening
all adults >20 years every 5 years
earlier and more often if familial hx
middle-older adults q1-2 years
when to start statin
LDL>100 + CV risk
maybe lower (LDL 55-70) for higher risk
low risk - >130 after lifestyle modification
women risk factor for CAD
PO contraception - d/c with dyslipidemia
statins AEs
myopathy/myosis, elevated LFTs, N/V/D, abd pain, HA, insomnia, rhabdo, hyperglycemia
statin monitoring
baseline LFTs
lipid panel at 6 week intervals
drug interactions
LFTs, CK if myalgias
consider decreasing dose when 2 consecutive LDL<40
statin contraindications
absolute - pregnancy, liver disease
relative - meds (cyclosporins, macrolides, antifungals, CYP 450 inhibitors)
ezetemibe indication, monitoring, CI
LDL reduction in statin-intolerant individuals or combo therapy
baseline LFTs
CI in hepatic impairment
bile acid sequesterants considerations & AE & CI
drug/drug interactions, vitamin malabsorption
may increase triglycerides, CI in TG>300
CONSTIPATION, dyspepsia, bloating, cramping, abd distention –>decrease adherence
CI in TG>300
hypertriglyceride treatment
TG>300
fibrates
niacin
fibrates AE, considerations, & CI
GI - abd bloating, N/V/D, gallstones
drug interactions ,monitor LFTs, monitor renal function
CI in renal & hepatic disease
niacin AE & monitoring & CI
flushing with itching
take ASA 30 mins before, take at night
monitor LFTs
CI - liver disease, severe gout
PCSK9 inhibitors
combo therapy w statin to lower LDL in those w family history
SQ injection
omega 3 fatty acid - icosapent ethyl
for marked hypertriglyceridemia
can increase LDL & prolong bleeding
serious risk in pregnancy
fadsfadfa
fasdfadsfa
CHD/CAD exam findings
S4
S3 - ventric dysfunction
obesity
leg edema
pulmonary congestion
diagonal ear crease
hair patterns